CLINICAL_TRIALS
trial_result
· 2016-11-03
Clinical Trial Update: Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout [Phase 3]
Summary
Phase 3 trial comparing extended-release and immediate-release febuxostat in gout patients evaluated efficacy and safety outcomes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Gout | Phase 3 | Status: COMPLETED | Results posted: 2016-11-03